Aldosterone

• 

  Subject Areas on Research

  • A WNK in the kidney controls blood pressure. 
  • A randomized controlled trial of renin-angiotensin-aldosterone system inhibitor management in patients admitted in hospital with COVID-19. 
  • Adrenal physiology and pharmacology. 
  • Adrenocortical hyperplasia occurring with metastatic carcinoma of the prostate: report of a case exhibiting increased urinary aldosterone and glucocorticoid excretion. 
  • Aldosterone Exposure Causes Increased Retinal Edema and Severe Retinopathy Following Laser-Induced Retinal Vein Occlusion in Mice. 
  • Aldosterone as a mediator of severity in retinal vascular disease: Evidence and potential mechanisms. 
  • Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells. 
  • Aldosterone, ion channels, and sudden death: another piece of the circle? 
  • Aldosterone-Induced Vascular Remodeling and Endothelial Dysfunction Require Functional Angiotensin Type 1a Receptors. 
  • Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors. 
  • Aldosterone: Behind the Scenes of Depression and Heart Failure? 
  • Angiotensin II acts through the angiotensin 1a receptor to upregulate pendrin. 
  • Angiotensin II and aldosterone in retinal vasculopathy and inflammation. 
  • Apparent treatment-resistant hypertension and chronic kidney disease: another cardiovascular-renal syndrome? 
  • Arterial pressure, left ventricular mass, and aldosterone in essential hypertension. 
  • Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism. 
  • Atrial natriuretic factor-specific antibody as a tool for physiological studies. Evidence for role of atrial natriuretic factor in aldosterone and renal electrolyte regulation. 
  • Atrial natriuretic factor: pharmacokinetics and cyclic GMP response in relation to biologic effects in severe heart failure. 
  • Beta2-adrenergic receptor genotype affects the renin-angiotensin-aldosterone system response to the Dietary Approaches to Stop Hypertension (DASH) dietary pattern. 
  • Binding of 3H-phenamil, an irreversible amiloride analog, to toad urinary bladder: effects of aldosterone and vasopressin. 
  • Biomarkers in acutely decompensated heart failure with preserved or reduced ejection fraction. 
  • CT in the diagnosis of primary aldosteronism: sensitivity in 29 patients. 
  • Cross-sectional relations of multiple biomarkers representing distinct biological pathways to plasma markers of collagen metabolism in the community. 
  • Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure. 
  • Differential effects of vitamin d receptor agonists on gene expression in neonatal rat cardiomyocytes. 
  • Disentangling the Relationships Between the Renin-Angiotensin-Aldosterone System, Calcium Physiology, and Risk for Kidney Stones. 
  • Distinct renin/aldosterone activity profiles correlate with renal function, natriuretic response, decongestive ability and prognosis in acute heart failure. 
  • Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. 
  • Effect of exogenous angiotensin II infusion after one year of captopril therapy in essential hypertension. 
  • Effects of two nonsteroidal anti-inflammatory drugs, indomethacin and oxaprozin, on the kidney. 
  • Enalapril in infants with single ventricle: results of a multicenter randomized trial. 
  • Failure of angiotensin II to reduce plasma renin activity in hypertensive pregnant women. 
  • Higher aldosterone and lower N-terminal proatrial natriuretic peptide as biomarkers of salt sensitivity in the community. 
  • Hyperrenin-hyperaldosterone-dependent malignant hypertension in polyarteritis nodosa. 
  • Kaliuretic peptide and long acting natriuretic peptide as well as atrial natriuretic factor inhibit aldosterone secretion. 
  • Laparoscopic adrenalectomy for pheochromocytoma. A comparison to aldosteronoma and incidentaloma. 
  • Maximizing benefits and mitigating risks with mineralocorticoid receptor antagonist therapy. 
  • Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study. 
  • Pathophysiology of Hypertension: The Mosaic Theory and Beyond. 
  • Primary hyperaldosteronism in pregnancy. 
  • Prostacyclin protects against elevated blood pressure and cardiac fibrosis. 
  • Regulation of sodium balance and blood pressure by the AT(1A) receptor for angiotensin II. 
  • Relation of the renin-angiotensin-aldosterone system to clinical state in congestive heart failure. 
  • Remission of progressive metastatic castration-resistant prostate cancer during abiraterone therapy following unilateral adrenalectomy for a functioning adrenal adenoma. 
  • Renal responses during a dry saturation dive to 450 msw. 
  • Renin-angiotensin-aldosterone genotype influences ventricular remodeling in infants with single ventricle. 
  • Renin-angiotensin-aldosterone system in nephrotic syndrome. 
  • Serum potassium is a predictor of incident diabetes in African Americans with normal aldosterone: the Jackson Heart Study. 
  • Sodium and water regulation in a patient with cerebral salt wasting. 
  • Steroid induction of therapy-resistant cytokeratin-5-positive cells in estrogen receptor-positive breast cancer through a BCL6-dependent mechanism. 
  • Surgical treatment of primary hyperaldosteronism. 
  • Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure. 
  • Targeted disruption of the mouse gene encoding steroidogenic acute regulatory protein provides insights into congenital lipoid adrenal hyperplasia. 
  • The association of serum vitamin D with incident diabetes in an African American population. 
  • The effect of aldosterone on water and electrolyte composition of incubated rat diaphragms. 
  • The inextricable role of the kidney in hypertension. 
  • Treatment Persistence of Renin-Angiotensin-Aldosterone-System Inhibitors Over Time in Heart Failure with Reduced Ejection Fraction. 
  • Ultrafiltration in Acute Heart Failure: Implications of Ejection Fraction and Early Response to Treatment From CARRESS-HF. 
  • Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines Committee. 
  • Urinary vasopressin and aldosterone and plasma volume during a saturation dive to 450 m. 
  • Vascular endothelial growth factor receptor 2 controls blood pressure by regulating nitric oxide synthase expression. 
• 

  Keywords of People

  • Barker, Piers Christopher Andrew, Professor of Pediatrics, Pediatrics, Cardiology
  • Pitt, Geoffrey Stuart, Adjunct Professor in the Department of Medicine, Medicine, Cardiology